Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)
Christopher Chin Keong Liam1,2,3, Jim Yu-Hsiang Tiao1,2, Yee Yee Yap3, Yi Lin Lee4, Jameela Sathar3, Simon McRae5, Amanda Davis6, Jennifer Curnow7, Robert Bird8, Philip Choi9, Pantep Angchaisuksiri10, Sim Leng Tien11, Joyce Ching Mei Lam12, Doyeun Oh13, Jin Seok Kim14, Sung-Soo Yoon15, Raymond Siu-Ming Wong16, Carolyn Lauren17, Eileen Grace Merriman18,19, Anoop Enjeti20, Mark Smith17, Ross Ian Baker1,2
1Perth Blood Institute, 2Western Australia Centre of Thrombosis and Haemostasis (WACTH), Murdoch University, Perth, Australia, 3Haematology, Hospital Ampang, 4Centre for Clinical Trials, Hospital Ampang, Selangor, Malaysia, 5Haematology, Northern Cancer Service, Tasmania, 6Haematology, The Alfred Hospital, Melbourne, 7Haematology, Westmead Hospital, New South Wales, 8Haematology, Princess Alexandra Hospital, Woolloongabba, Queensland, 9Haematology, The Canberra Hospital, Canberra, Australia, 10Haematology and Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 11Haematology, Singapore General Hospital, 12Haematology, KK Women's and Children's Hospital, Singapore, 13Internal Medicine, Cha Bundang Medical Centre, Cha University, Seongnam, 14Internal Medicine, Yonsei University College of Medicine, 15Internal Medicine, Seoul National University Hospital, Seoul, Korea, 16Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, 17Haematology, Canterbury District Health Board, Christchurch, 18Haematology, North Shore Hospital, 19Haematology, Waitemata District Health Board, Auckland, New Zealand, 20Calvery Mater Hospital Newcastle, Waratah, New South Wales, Australia